Characteristics of Turkish colorectal cancer patients and bevacizumab preference.

dc.authoridCicin, Irfan/0000-0002-7584-3868
dc.authoridÖksüzoğlu Çakmak, Ömür Berna/0000-0002-2756-8646
dc.authoridElkıran, Emin Tamer/0000-0001-6681-7249
dc.authoridOzyilkan, Ozgur/0000-0001-8825-4918
dc.authoridKilickap, Saadettin/0000-0003-1637-7390
dc.authoridUslu, Ruchan/0000-0002-9584-6134
dc.authoridTurna, Hande/0000-0003-0558-9371
dc.authorwosidKaraoglu, Aziz/HKM-3509-2023
dc.authorwosidCicin, Irfan/AAQ-5575-2020
dc.authorwosidÖksüzoğlu Çakmak, Ömür Berna/HKN-6428-2023
dc.authorwosidGumus, Mahmut/C-7135-2008
dc.authorwosidGumus, Mahmut/HTO-4176-2023
dc.authorwosidElkıran, Emin Tamer/ABI-8192-2020
dc.authorwosidOzyilkan, Ozgur/AAD-2817-2021
dc.contributor.authorCicin, Irfan
dc.contributor.authorGumus, Mahmut
dc.contributor.authorUncu, Dogan
dc.contributor.authorOzkan, Metin
dc.contributor.authorKilickap, Saadettin
dc.contributor.authorElkiran, Tamer E.
dc.contributor.authorIsikdogan, Abdurrahman
dc.date.accessioned2024-08-04T20:57:21Z
dc.date.available2024-08-04T20:57:21Z
dc.date.issued2017
dc.departmentİnönü Üniversitesien_US
dc.description53rd Annual Clinical Science Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Symposium on Old Targets, New Drugs - Her2 and MET -- JUN 02-07, 2017 -- Chicago, ILen_US
dc.description.abstract[Abstract Not Available]en_US
dc.description.sponsorshipAmer Soc Clin Oncolen_US
dc.identifier.doi10.1200/JCO.2017.35.15_suppl.e15055
dc.identifier.issn0732-183X
dc.identifier.issn1527-7755
dc.identifier.urihttps://doi.org/10.1200/JCO.2017.35.15_suppl.e15055
dc.identifier.urihttps://hdl.handle.net/11616/102567
dc.identifier.volume35en_US
dc.identifier.wosWOS:000411895707157en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherAmer Soc Clinical Oncologyen_US
dc.relation.ispartofJournal of Clinical Oncologyen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[No Keywords]en_US
dc.titleCharacteristics of Turkish colorectal cancer patients and bevacizumab preference.en_US
dc.typeConference Objecten_US

Dosyalar